AirSculpt Technologies, Inc. (AIRS)
USD 2.94
(-11.45%)
USD 2.94
(-11.45%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 195.91 Million USD | 16.07% |
| 2022 | 168.79 Million USD | 26.61% |
| 2021 | 133.31 Million USD | 112.4% |
| 2020 | 62.76 Million USD | 52.21% |
| 2019 | 41.23 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 51 Million USD | 7.11% |
| 2024 Q1 | 47.62 Million USD | 0.03% |
| 2023 Q2 | 55.7 Million USD | 21.59% |
| 2023 Q1 | 45.81 Million USD | 12.55% |
| 2023 FY | 195.91 Million USD | 16.07% |
| 2023 Q4 | 47.6 Million USD | 1.74% |
| 2023 Q3 | 46.79 Million USD | -16.0% |
| 2022 Q1 | 39.54 Million USD | 5.29% |
| 2022 Q3 | 38.89 Million USD | -21.67% |
| 2022 Q2 | 49.65 Million USD | 25.57% |
| 2022 FY | 168.79 Million USD | 26.61% |
| 2022 Q4 | 40.7 Million USD | 4.66% |
| 2021 Q2 | 34.96 Million USD | 33.76% |
| 2021 FY | 133.31 Million USD | 112.4% |
| 2021 Q4 | 37.55 Million USD | 8.38% |
| 2021 Q3 | 34.65 Million USD | -0.9% |
| 2021 Q1 | 26.14 Million USD | 14.44% |
| 2020 Q4 | 22.84 Million USD | 28.07% |
| 2020 Q3 | 17.83 Million USD | 61.52% |
| 2020 Q2 | 11.04 Million USD | 0.0% |
| 2020 Q1 | 11.04 Million USD | 0.0% |
| 2020 FY | 62.76 Million USD | 52.21% |
| 2019 FY | 41.23 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 93.311% |
| Addus HomeCare Corporation | 1.05 Billion USD | 81.494% |
| Amedisys, Inc. | 2.23 Billion USD | 91.24% |
| American Oncology Network, Inc. | 1.27 Billion USD | 84.684% |
| Astrana Health, Inc. | 1.38 Billion USD | 85.871% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 89.663% |
| IMAC Holdings, Inc. | 5.19 Million USD | -3669.81% |
| biote Corp. | 185.36 Million USD | -5.695% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -525.06% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 90.3% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 68.618% |
| The Ensign Group, Inc. | 3.72 Billion USD | 94.747% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 88.278% |
| InnovAge Holding Corp. | 763.85 Million USD | 74.352% |
| Assure Holdings Corp. | 255 Thousand USD | -76730.196% |
| The Joint Corp. | 117.69 Million USD | -66.46% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 81.441% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -1791.361% |
| ModivCare Inc. | 2.75 Billion USD | 92.879% |
| NewGenIvf Group Limited | 5.13 Million USD | -3714.47% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -1458.357% |
| Option Care Health, Inc. | 4.3 Billion USD | 95.446% |
| P3 Health Partners Inc. | 1.26 Billion USD | 84.529% |
| P3 Health Partners Inc. | 1.26 Billion USD | 84.529% |
| The Pennant Group, Inc. | 544.89 Million USD | 64.045% |
| Surgery Partners, Inc. | 2.74 Billion USD | 92.858% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -3452.346% |
| Talkspace, Inc. | 150.04 Million USD | -30.572% |
| Talkspace, Inc. | 150.04 Million USD | -30.572% |
| The Oncology Institute, Inc. | 324.23 Million USD | 39.576% |
| The Oncology Institute, Inc. | 324.23 Million USD | 39.576% |